UnitedHealth Group (NYSE:UNH) Price Target Lowered to $600.00 at Oppenheimer

UnitedHealth Group (NYSE:UNH - Free Report) had its target price lowered by Oppenheimer from $640.00 to $600.00 in a research report sent to investors on Monday,Benzinga reports. Oppenheimer currently has an outperform rating on the healthcare conglomerate's stock.

A number of other brokerages also recently weighed in on UNH. Cantor Fitzgerald reissued an "overweight" rating and issued a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Hsbc Global Res raised UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research note on Friday, January 10th. Argus downgraded UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Monday. Mizuho upped their price objective on shares of UnitedHealth Group from $600.00 to $650.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. Finally, Piper Sandler cut their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a report on Thursday, January 2nd. Three investment analysts have rated the stock with a hold rating, nineteen have given a buy rating and three have given a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Buy" and an average target price of $603.05.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH traded down $6.34 during trading hours on Monday, hitting $417.91. The stock had a trading volume of 6,670,446 shares, compared to its average volume of 5,689,983. UnitedHealth Group has a 1-year low of $412.02 and a 1-year high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The firm has a market capitalization of $382.27 billion, a price-to-earnings ratio of 26.96, a PEG ratio of 1.37 and a beta of 0.61. The stock's fifty day simple moving average is $504.95 and its 200 day simple moving average is $536.14.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period in the previous year, the business posted $6.91 EPS. Sell-side analysts anticipate that UnitedHealth Group will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.01%. UnitedHealth Group's dividend payout ratio is currently 35.18%.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the stock. Norges Bank acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth $6,375,744,000. GAMMA Investing LLC lifted its position in UnitedHealth Group by 56,142.1% during the 1st quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock worth $4,344,586,000 after acquiring an additional 8,280,404 shares during the last quarter. Raymond James Financial Inc. bought a new position in shares of UnitedHealth Group in the fourth quarter worth about $1,914,740,000. Amundi increased its position in UnitedHealth Group by 97.2% in the 4th quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate's stock worth $3,183,132,000 after buying an additional 2,991,470 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of UnitedHealth Group by 36.6% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock worth $4,346,712,000 after acquiring an additional 2,301,010 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.